HIF1A and Parkinson disease: Supporting this idea, Fujimaki et al. [56] demonstrated that activation of HIF-1α by the prolyl hydroxylase inhibitor FG-4592 in a PD model overexpressing α-synuclein promoted a comprehensive cytoprotective response.